Diabetes treatment lowers PromarkerD risk score: Results presented at Australasian Diabetes Congress

Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to provide a copy of its conference presentation to the Australasian Diabetes Congress in Brisbane, 11-13 August 2021, titled “Canagliflozin attenuates PromarkerD diabetic kidney disease risk prediction scores”.

Media Release